Potential downstream effectors of RAGE activation, such as TNF‐α, have recently been shown to be a disease promoting condition, as TNF‐α receptor blockade using a recombinant human TNF‐α receptor‐antibody fusion protein obviously alleviates streptozotocin‐induced DN in rats (Shi et al., 2013). Here, TNF is linked to liver dysplastic nodule.